UnitedHealth Group delivered strong Q4 and full-year 2015 results, aligning with expectations and showcasing robust growth across its businesses. Key positive highlights include exceptional Optum performance, strong cash flows, a growing member base, and strategic expansions. Although there is some cautiousness regarding the continued challenges in exchange markets, the company has managed expectations prudently, with a focus on risk adjustments and growth in other areas. The overall tone and forward guidance suggest a positive outlook, likely supporting upward momentum in the stock price over the next 1â€“2 weeks.

[1]